Assessing AtriCure's Valuation After a 33.4% Rally in 2025 [Yahoo! Finance]
AtriCure, Inc. (ATRC)
Last atricure, inc. earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.atricure.com
Company Research
Source: Yahoo! Finance
The stock is up 7.4% over the last month and 33.4% year to date, but those gains sit against a much weaker 3 year and 5 year track record. That contrast hints at shifting sentiment and risk perceptions. Recent coverage has focused on AtriCure's position in minimally invasive cardiac ablation and left atrial appendage management devices, and how hospitals are leaning into technologies that reduce complications and length of stay. At the same time, investors are paying closer attention to procedure volume trends and competitive dynamics in cardiac surgery devices, which helps explain some of the renewed interest in the stock. On our valuation framework AtriCure scores just for being undervalued. We will walk through what the main valuation approaches say about the stock now, before circling back at the end to what may be a more powerful way to think about its true worth. AtriCure scores just 2/6 on our valuation checks. See what other red flags we found in the full valuation brea
Show less
Read more
Impact Snapshot
Event Time:
ATRC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ATRC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ATRC alerts
High impacting AtriCure, Inc. news events
Weekly update
A roundup of the hottest topics
ATRC
News
- AtriCure (ATRC): Assessing Valuation After First-In-Human PFA/RFA Procedures and Renewed Analyst Optimism [Yahoo! Finance]Yahoo! Finance
- Analysts See an Over 26% Upside in AtriCure (ATRC) [Yahoo! Finance]Yahoo! Finance
- AtriCure to Participate in the J.P. Morgan 44th Annual Healthcare ConferenceBusiness Wire
- AtriCure (NASDAQ:ATRC) had its price target raised by analysts at JPMorgan Chase & Co. from $42.00 to $48.00. They now have an "overweight" rating on the stock.MarketBeat
- AtriCure (ATRC) Is Up 6.3% After Dual Energy PFA–RFA First-in-Human Success - Has The Bull Case Changed? [Yahoo! Finance]Yahoo! Finance
ATRC
Earnings
- 10/29/25 - Beat
ATRC
Sec Filings
- 12/12/25 - Form 4
- 11/26/25 - Form 4
- 11/26/25 - Form 4
- ATRC's page on the SEC website